Most important barriers and facilitators of HTA usage in decision-making in Europe

K. L. Cheung, S. M. A. A. Evers, H. De Vries, P. Levy, S. Pokhrel, T. Jones, M. Danner, J. Wentlandt, L. Knufinke, S. Mayer, M. Hiligsmann

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)297-304
Number of pages8
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume18
Issue number3
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • Europe
  • health technology assessment
  • barriers
  • facilitators
  • best-worst
  • HEALTH TECHNOLOGY-ASSESSMENT
  • COST-EFFECTIVENESS ANALYSIS
  • ECONOMIC-EVALUATION
  • RESOURCE-ALLOCATION
  • CARE
  • WORST
  • ASSESSMENTS
  • COUNTRIES
  • IMPACT

Cite this